Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy
Status:
Withdrawn
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This study will determine whether an acute infusion of intravenous allopurinol improves the
inotropic response to dobutamine in patients with idiopathic dilated cardiomyopathy (DCM) as
measured by cardiac magnetic resonance imaging (CMR).